# Method for B Cell Receptor Enrichment in Malignant B Cells

**Authors:** Puja Bhattacharyya, Richard I. Christopherson, Kristen K. Skarratt, Stephen J. Fuller

PMC · DOI: 10.3390/cancers16132341 · Cancers · 2024-06-26

## TL;DR

This paper introduces a new method to enrich B cell receptors for detailed proteomic analysis, which could improve understanding of B cell cancers.

## Contribution

A novel MS-compatible enrichment technique for BCR complexes using Protein G pull down with intermediary antibodies.

## Key findings

- The method successfully pulls down the entire BCR complex using antibodies against CD79a, CD79b, and membrane immunoglobulin.
- The technique is compatible with mass spectrometry and can enrich all BCR isotypes, unlike prior methods limited to mIgG.

## Abstract

The B cell receptor (BCR) is a membrane-bound protein complex that is required for the normal development of B cells. BCR signalling is also involved in the pathogenesis of B cell cancers. While there is substantial literature on genomic analyses of the BCR, there are limited proteomic studies of receptor structure and its interactions with neighbouring proteins. This is partly due to the location of the BCR in the surface-membrane lipid environment that has limited the ability to enrich the complex for proteomic analysis. Here, we report an enrichment technique that can be used for mass spectrometry analyses of the BCR from live B cells.

B cells are central to the adaptive immune response and provide long-lasting immunity after infection. B cell activation is mediated by the surface membrane-bound B cell receptor (BCR) following recognition of a specific antigen. The BCR has been challenging to analyse using mass spectrometry (MS) due to the difficulty of isolating and enriching this membrane-bound protein complex. There are approximately 120,000 BCRs on the B cell surface; however, depending on the B cell activation state, there may be hundreds-of-millions to billions of proteins in a B cell. Consequently, advanced proteomic techniques such as MS workflows that use purified proteins to yield structural and protein-interaction information have not been published for the BCR complex. This paper describes a method for enriching the BCR complex that is MS-compatible. The method involves a Protein G pull down on agarose beads using an intermediary antibody to each of the BCR complex subcomponents (CD79a, CD79b, and membrane immunoglobulin). The enrichment process is shown to pull down the entire BCR complex and has the advantage of being readily compatible with further proteomic study including MS analysis. Using intermediary antibodies has the potential to enrich all isotypes of the BCR, unlike previous methods described in the literature that use protein G-coated beads to directly pull down the membrane IgG (mIgG) but cannot be used for other mIg isotypes.

## Linked entities

- **Genes:** CD79A (CD79a molecule) [NCBI Gene 973], CD79B (CD79b molecule) [NCBI Gene 974]
- **Proteins:** BCR (BCR activator of RhoGEF and GTPase)

## Full-text entities

- **Genes:** CD79B (CD79b molecule) [NCBI Gene 974] {aka AGM6, B29, IGB, Igbeta}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}
- **Diseases:** infection (MESH:D007239)
- **Chemicals:** agarose (MESH:D012685)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11240526/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11240526/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC11240526/full.md

---
Source: https://tomesphere.com/paper/PMC11240526